Advertisement

Organisation › Details
Expression Pathology Inc. (EPI)
Expression Pathology is advancing personalized medicine with assays that measure cancer signaling networks—at the functional protein level—in FFPE tissue to individualize and improve patient treatment decisions. Expression Pathology's patented Liquid Tissue®-SRM technology platform makes possible highly multiplexed protein quantitation by powerful mass spectrometry of minute amounts of laser microdissected FFPE tissue. Expression Pathology offers a broad menu of multiplexed SRM assays for major cancer signaling networks to advance development of targeted therapies and improve patient stratification. The assays include a range of drug target pathway proteins including EFGR, IGF-1R, cMET, Her3, cSRC, MEK, and their phosphorylation states, as well as many others. *
![]() |
Start | 2003-07-11 existent |
![]() |
End | 2012-06-01 renamed before |
Group | OncoPlex Diagnostics (OncoPlexDx) | |
Today | OncoPlex Diagnostics (OncoPlexDx) | |
Successor | OncoPlex Diagnostics (OncoPlexDx) | |
![]() |
Industry | tissue microarray |
Industry 2 | cancer test | |
![]() |
Region | Rockville, MD |
Country | United States (USA) | |
Street | 9620 Medical Center Drive Suite 100 | |
City | 20850 Rockville, MD | |
Tel | +1-301-977-3654 | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: | ||
Record changed: 2018-10-31 |
Advertisement

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com
Advertisement

» top